WHO: Ebola outbreak response in DRC is catching up but faces challenges
Hızlı Bakış
- The WHO stated that the Ebola outbreak response in the DRC is catching up but faces challenges like insufficient lab capacity, travel restrictions, and community mistrust.
- The outbreak has caused 344 cases and 60 deaths in DRC, and 15 cases and 1 death in Uganda.
- Over $1.15 billion is needed for the next three months.
Yapay zekâ özeti
Neden Önemli?
The World Health Organization held a press conference regarding the Ebola outbreak in the Democratic Republic of Congo (DRC). The outbreak has led to 344 confirmed cases and 60 deaths in the DRC, and 15 cases and 1 death in neighboring Uganda. The WHO notes that while the response is improving, significant challenges persist.
中新社北京6月4日电 综合消息：世界卫生组织当地时间3日在瑞士日内瓦就刚果(金)本迪布焦型埃博拉疫情举行新闻发布会，指该国本轮疫情防控工作正在“迎头赶上”，但仍面临一些挑战。
据世卫组织官网报道，世卫组织总干事谭德塞2日结束对刚果(金)的访问并返回。他表示，尽管挑战依然存在，“但我看到的景象给了我希望”。
据介绍，刚果(金)已报告确诊病例344例，其中死亡60例。疑似病例数从上周的1000多例减少至116例，积压样本的检测工作正在进行中。此外，刚果(金)邻国乌干达报告15例确诊病例、1例死亡病例。
谭德塞说，目前，刚果(金)已有6人康复，乌干达已有2人康复。“这表明，如果人们能够获得护理，并在出现症状后立即前往医疗机构，就有可能战胜埃博拉病毒。”
与此同时，谭德塞指出，疫情防控工作当前仍面临一些挑战，包括实验室数量和检测能力不足、部分国家实施全面旅行限制阻碍疫情应对工作、社区不信任等。
谭德塞说，刚果(金)的接触者追踪比例尚未达到所需水平。目前只有约45%的接触者得到追踪，而要控制疫情，这一比例需要提高到90%以上。“不安全、流离失所和流动人口使追踪接触者变得尤其困难。”
另一项挑战在于，本轮疫情由本迪布焦型埃博拉病毒引起，目前尚无获批疫苗和特异性治疗方法。
综合美联社与联合国新闻网报道，向有关地区提供潜在疫苗可能需要几个月的时间。目前有三种疫苗正在研发中。
另据路透社消息，世卫组织突发卫生事件规划执行主任齐克韦·伊赫克韦祖(Chikwe Ihekweazu)表示，在未来三个月，该机构至少需要1.15亿美元来应对疫情，目前已筹资约35%。
世卫组织对本轮疫情的风险评估保持不变，即在刚果(金)国家层面风险为“非常高”，在地区层面为“高”，在全球层面为“低”。(完)
Bundan Sonra Ne Olabilir?
Yapay zekâ öngörüsü — kesinlik taşımaz
The WHO will continue to face challenges in contact tracing due to insecurity, displacement, and mobile populations.
Çok muhtemel · Aylar içinde
The development and provision of potential vaccines will take several months.
Muhtemel · Aylar içinde
The WHO will need to raise an additional $74.75 million to meet its funding requirements for the next three months.
Çok muhtemel · Kısa vadede
Açık Sorular
- What specific measures are being taken to address community mistrust?
- How will the WHO overcome the lack of approved vaccines and specific treatments?
- What are the projected timelines for the development and deployment of new vaccines?
- What are the specific impacts of travel restrictions on the response efforts?
